Cardiomyopathy Trial, Recruiting NCT06575881 Sponsor: Vanderbilt University Medical Center Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06575881
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who were diagnosed with an irregular heart rhythm condition — either atrial fibrillation (AF), frequent extra heartbeats from the lower heart (PVCs), or a fast abnormal heart rhythm (VT) — before the age of 60
  • People who are already scheduled for a catheter-based procedure to treat AF, PVCs, or VT (either for the first time or as a repeat procedure)
  • People who are able to give written consent to participate
  • People who have either a specific harmful or likely harmful change in a heart-related gene (such as the TTN gene), or have been confirmed through genetic testing to have no such gene change (confirm with trial site)

Who may not be able to join:

  • People who had already been diagnosed with a genetic heart muscle disease or inherited heart rhythm condition before their ablation procedure
  • People in the control group who have a gene change classified as being of uncertain significance in a specific higher-risk category (confirm with trial site)
  • People who have previously had a catheter-based procedure to treat PVCs or VT
  • People whose heart pumping function is severely reduced (left heart pumping strength below 20%)
  • People who have an artificial mitral or aortic heart valve
  • People who cannot safely receive the blood-thinning medication heparin
  • People who have previously had a heart attack

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 615-936-6069

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 December 2023
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Ventricular Tachycardia Inducibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov